XBiotech logo
XBiotech
XBIT | NASDAQ
Chart Builder DCF Calculator
$1.85
-$0.10 (-5.37%)
At close: Nov 16, 2026, 4:00 PM ET
$1.81
-$0.04 (-2.16%)
After-hours: Nov 16, 2026, 7:21 PM ET

XBiotech Company Profile

Company profile explained

Company Profile

XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline of product candidates aimed at combating both inflammatory and infectious diseases. Furthermore, the company is advancing interleukin-1 alpha-based therapies, which are designed to address a broad spectrum of medical conditions such as cancer, stroke, heart attack, and arthritis. Interleukin-1 alpha itself plays a crucial role in biological processes like tissue breakdown, angiogenesis, blood clot formation, malaise, muscle wasting, and inflammation. Additionally, XBiotech is developing a True Human COVID-19 therapy specifically targeting mutant strains of the virus. Established in 2005, XBiotech Inc. maintains its headquarters in Austin, Texas.

Key Executives

Name Position
Sushma Shivaswamy Interim CEO & Chief Scientific Officer
Angela Hu Director of Finance
John Simard Founder & Chairman
Qian Wu Senior Vice President of Clinical Operations & Analytical Quality

Latest SEC Filings

Date Type Title
Oct 28, 2026 4 Filing
Oct 28, 2026 3 Filing
Oct 28, 2026 4 Filing
Oct 26, 2026 8-K Current Report
Oct 02, 2026 ARS Filing
Oct 02, 2026 DEF 14A Filing
Aug 13, 2026 10-Q Quarterly Report
May 14, 2026 10-Q Quarterly Report
Apr 29, 2026 10-K/A [Amend] Annual Report
Mar 13, 2026 10-K Annual Report
View All SEC Filings ➞
XBiotech
XBiotech logo
Country United States
IPO Date Apr 15, 2015
Industry Biotechnology
Sector Healthcare
Employees 87
CEO Sushma Shivaswamy

Contact Details

5217 Winnebago Lane Austin, Texas 78744 United States

Stock Details

Ticker Symbol XBIT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001626878
CUSIP Number 98400H102
ISIN Number CA98400H1029
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.